TCM
KURA icon

Tekla Capital Management’s Kura Oncology KURA Stock Holding History

Tekla Capital Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-283,281
Closed -$3.46M – 173
2023
Q1 		$3.46M Hold
283,281
– – 0.13% 89
2022
Q4 		$3.52M Buy
+283,281
New +$4.12M 0.13% 87
2021
Q4 		– Sell
-273,463
Closed -$5.12M – 176
2021
Q3 		$5.12M Hold
273,463
– – 0.16% 106
2021
Q2 		$5.7M Hold
273,463
– – 0.19% 114
2021
Q1 		$7.73M Hold
273,463
– – 0.27% 95
2020
Q4 		$8.93M Buy
273,463
+214,124
+361% +$7.52M 0.31% 87
2020
Q3 		$1.82M Buy
+59,339
New +$1.31M 0.07% 160

Other funds holding KURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Tekla Capital Management's KURA Position: Q2 2023 in Review

Tekla Capital Management sold out of Kura Oncology (KURA) in Q2 2023, closing a stake of 283,281 shares — an estimated $3.46M sold.

Tekla Capital Management first reported a position in KURA in Q3 2020 and held it in 7 quarters. The position peaked at $8.93M in Q4 2020. 148 funds tracked by Wall St. Rank hold KURA as of Q2 2023.

  • Tekla Capital Management reported no remaining Kura Oncology position as of Q2 2023 after selling out during the quarter.
  • Tekla Capital Management sold 283,281 Kura Oncology shares in Q2 2023, an estimated $3.46M.
  • Tekla Capital Management first reported a position in Kura Oncology in Q3 2020 and held it in 7 quarters.
  • Tekla Capital Management's Kura Oncology position peaked at $8.93M in Q4 2020.
  • 148 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2023.

Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.